Navigation Links
Genmab Announces Results for the First Nine Months of 2007
Date:10/30/2007

Summary: Genmab Reports Results for the Nine Month Period Ended September

30, 2007

Genmab, October 30 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today results for the nine month period ended September 30, 2007, as follows:

Revenues of DKK 356.1 million (approx. USD 67.7 million) for the nine month period ended September 30, 2007. In the same period of 2006, Genmab recognised DKK 105.6 million (approx. USD 20.1 million) in revenues.

An Operating Loss of DKK 309.0 million (approx. USD 58.8 million). This compares to an Operating Loss of DKK 324.1 million (approx. USD 61.7 million) reported for the corresponding period of 2006.

Net Financial Income totalled DKK 47.7 million (approx. USD 9.1 million), compared to Net Financial Income of DKK 22.7 million (approx. USD 4.3 million) in the nine month period ended September 30, 2006. Net financial income has benefited from the higher average cash position in 2007.

A Net Loss of DKK 261.2 million (approx. USD 49.7 million) compared to a Net Loss of DKK 301.5 million (approx. USD 57.3 million) for the same period in 2006. The Net Loss per share was DKK 5.97 (approx. USD 1.14) for the nine month period ended September 30, 2007 compared to DKK 7.79 (approx. USD 1.48) in the nine month period ended September 30, 2006.

Genmab ended the nine month period with a cash position of DKK 3.921 billion (approx. USD 746 million), which is a net increase of DKK 2.197 billion (approx. USD 417.9 million) from the end of 2006.

Highlights

During the third quarter of 2007, Genmab achieved a number of business and scientific milestones, including:

Regaining all rights to the HuMax-TAC(TM) antibody from Merck Serono following a portfolio review.

Roche filing an investigational new drug application (IND) with the FDA for a Genmab antibody.

Initiation of a Phase III clinical study of HuMax-EGFr(TM) (zalutumumab) to treat front li
'/>"/>

SOURCE Genmab A/S
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...es, Dec. 2 Spectrum Blue Steel is emerging as one...the planet. Through the efforts of True Green Ener...ycling Specialist Leroy Johnston, who has been in ...hat Spectrum Blue Steel is light years ahead of ev...rnings because of the bi products recovered by usi...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces that a new mar... ,, Carbondioxide Incubators - A Global Market Pe...8/Carbondioxide-Incubators---A-Global-Market-Persp...equipment used in microbiology, genetics, cancer, ...ontrolled environment to grow and store biological...
(Date:12/2/2009)...2 Nearly 600 medical research executives, scienti...explore novel development approaches and innovativ...for Cures meeting. ,, FasterCures, the Washing... Partnering for Cures to facilitate multi-sector...ery into an accessible therapy. This effort unite...
(Date:12/2/2009)...., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq...ollment in a dose confirmation and dosimetry trial...stoma multiforme (GBM), the deadliest form of brai...y linked to a radioisotope being developed as a po...y targets cells at the center of brain tumors, so ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
..., March 13 /PRNewswire-FirstCall/ -- DOR BioPhar...mpany) announced today that it has appointed Brian...d Chief Medical Officer. Dr. Hamilton is a recogni...ally active steroids as well as in Graft-versus-Ho...shed career of more than 25 years in both academia...
... Some of the world,s most respected e...security questions during a daylong gathering in H...eater Houston Partnership once again takes center ...hosting "America,s Energy Future: Assessing O... Houston (PRWEB) March 13, 2009 -- Pres...
... N.J., March 12 Schering-Plough Corporation (NYSE...arnings results for the 2009 first quarter on Tues...that day, Schering-Plough will conduct a conferenc...r. Fred Hassan, Schering-Plough,s chairman and CE...onference call. , , To listen live to the call, ...
Other Biology Technology:DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 2DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 3DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 4DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 5Greater Houston Partnership to Lead Energy Security Discussion 2
(Date:12/3/2009)...mes to investment in energy efficient technologies...esearch Council (EPSRC) Chief Executive Dave Delpy...ineering research has already brought us fuel cell...e investment is needed to develop the capabilities...on emission targets by 2020 and limit the impact o...
(Date:12/2/2009)...strengthen the evidence that people who smoke ciga...d risk for developing colorectal cancer, even afte...ides one more reason not to smoke, or to quit as s...un, M.D., M.S., vice president emeritus, epidemiol...er Society. "Colorectal cancer should be added to ...
(Date:12/2/2009)...er-free status did not prompt people participating...cancer screening program to pick up their cigarett...n Cancer Epidemiology, Biomarkers & Prevention , ...esearch. The December issue contains a special foc...espread concern in the lung screening community th...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Questions to Pharmacists Rise After Michael Jacksons Death 51194 1Questions to Pharmacists Rise After Michael Jacksons Death 51194 2Universal Health Services Inc Announces Dividend 51192 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 2
...ose of chemotherapy drugs to specific cancer cells... may one day be possible thanks to a nanoscale dru... the U.S. Department of Energy,s Ames Laboratory. ...spheres to carry drugs inside living cells, Ames L... methods to control whether or not the particle de...
...ene-coated gold particles protect mice against a p...ers at UT Southwestern Medical Center have found. ...roducing the specific protein ?called amyloid-beta...odies and greatly reduce the protein,s build-up in...ans is a hallmark of Alzheimer,s disease. , "The ...
...hool of Medicine researchers have identified the p...e first line of defense against invading pathogens...site this week and will be published in a future i...re body is formed in the skin by a group of cells ...gens present in the skin and transport them to lym...
Other Biology News:Cellular scale drug delivery from the inside out 2Cellular scale drug delivery from the inside out 3DNA gene vaccine protects against harmful protein of Alzheimer's disease 2Source of crucial immune cell in the skin discovered 2
Feline serum from Equitech-Bio
Donor feline Serum - 500mL from Biomeda Corporation
Paraffin Tissue Section Panel - Monkey (Simian) Normal Tissue, Multi-tissue I from BioChain
Mouse Anti-Rabbit ryanodine receptor, skeletal Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: